• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of NDI notification reviews completed during the month within 75 days of filing

Dictionary: Timely review of notifications of new dietary ingredients impacts the public health by preventing substances that are not actually dietary ingredients from being used in dietary supplements, and assuring that new dietary ingredients have adequate evidence for presumption of safety. Since these statutory requirements are notifications rather than pre-market approvals, it is essential that ONLDS have completed review of the information before the submitter markets the product, to notify them of any safety or regulatory concerns before the product reaches consumers.

Information is current as of December 31, 2013.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeAnnual TargetPercentage
Oct 201190100
Nov 201190100
Dec 201190100
Jan 201290100
Feb 201290100
Mar 201290100
Apr 201290100
May 201290100
Jun 201290100
Jul 201290100
Aug 201290100
Sep 201290100

FY 2012 Overall: 100%

Number of NDI notification reviews due to be completed during the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A3
Nov 2011N/A5
Dec 2011N/A4
Jan 2012N/A2
Feb 2012N/A4
Mar 2012N/A3
Apr 2012N/A6
May 2012N/A2
Jun 2012N/A4
Jul 2012N/A6
Aug 2012N/A3
Sep 2012N/A3

FY 2012 Total: 45

Number of NDI notification reviews completed during the month within 75 days of filing

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A3
Nov 2011N/A5
Dec 2011N/A4
Jan 2012N/A2
Feb 2012N/A4
Mar 2012N/A3
Apr 2012N/A6
May 2012N/A2
Jun 2012N/A4
Jul 2012N/A6
Aug 2012N/A3
Sep 2012N/A3

FY 2012 Total: 45

Total number of NDI notification reviews completed during the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A3
Nov 2011N/A5
Dec 2011N/A4
Jan 2012N/A2
Feb 2012N/A4
Mar 2012N/A3
Apr 2012N/A6
May 2012N/A2
Jun 2012N/A4
Jul 2012N/A6
Aug 2012N/A3
Sep 2012N/A3

FY 2012 Total: 45

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.